Cargando…

Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives

Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Osorio, Julio C., Blanco, Rancés, Corvalán, Alejandro H., Muñoz, Juan P., Calaf, Gloria M., Aguayo, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878590/
https://www.ncbi.nlm.nih.gov/pubmed/35215076
http://dx.doi.org/10.3390/pathogens11020132
_version_ 1784658695230062592
author Osorio, Julio C.
Blanco, Rancés
Corvalán, Alejandro H.
Muñoz, Juan P.
Calaf, Gloria M.
Aguayo, Francisco
author_facet Osorio, Julio C.
Blanco, Rancés
Corvalán, Alejandro H.
Muñoz, Juan P.
Calaf, Gloria M.
Aguayo, Francisco
author_sort Osorio, Julio C.
collection PubMed
description Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein–Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy.
format Online
Article
Text
id pubmed-8878590
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88785902022-02-26 Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives Osorio, Julio C. Blanco, Rancés Corvalán, Alejandro H. Muñoz, Juan P. Calaf, Gloria M. Aguayo, Francisco Pathogens Review Lung cancer (LC) is the leading cause of cancer death worldwide. Tobacco smoke is the most frequent risk factor etiologically associated with LC, although exposures to other environmental factors such as arsenic, radon or asbestos are also involved. Additionally, the involvement of some viral infections such as high-risk human papillomaviruses (HR-HPVs), Merkel cell polyomavirus (MCPyV), Jaagsiekte Sheep Retrovirus (JSRV), John Cunningham Virus (JCV), and Epstein–Barr virus (EBV) has been suggested in LC, though an etiological relationship has not yet been established. EBV is a ubiquitous gamma herpesvirus causing persistent infections and some lymphoid and epithelial tumors. Since EBV is heterogeneously detected in LCs from different parts of the world, in this review we address the epidemiological and experimental evidence of a potential role of EBV. Considering this evidence, we propose mechanisms potentially involved in EBV-associated lung carcinogenesis. Additional studies are warranted to dissect the role of EBV in this very frequent malignancy. MDPI 2022-01-21 /pmc/articles/PMC8878590/ /pubmed/35215076 http://dx.doi.org/10.3390/pathogens11020132 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Osorio, Julio C.
Blanco, Rancés
Corvalán, Alejandro H.
Muñoz, Juan P.
Calaf, Gloria M.
Aguayo, Francisco
Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title_full Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title_fullStr Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title_full_unstemmed Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title_short Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
title_sort epstein–barr virus infection in lung cancer: insights and perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878590/
https://www.ncbi.nlm.nih.gov/pubmed/35215076
http://dx.doi.org/10.3390/pathogens11020132
work_keys_str_mv AT osoriojulioc epsteinbarrvirusinfectioninlungcancerinsightsandperspectives
AT blancorances epsteinbarrvirusinfectioninlungcancerinsightsandperspectives
AT corvalanalejandroh epsteinbarrvirusinfectioninlungcancerinsightsandperspectives
AT munozjuanp epsteinbarrvirusinfectioninlungcancerinsightsandperspectives
AT calafgloriam epsteinbarrvirusinfectioninlungcancerinsightsandperspectives
AT aguayofrancisco epsteinbarrvirusinfectioninlungcancerinsightsandperspectives